Evonik rejects BASF takeover approach in potential €10.3bn chemicals deal

Evonik rejects BASF takeover approach in potential €10.3bn chemicals deal
Evonik rebuffs BASF offer

Consolidation pressure is building across Europe’s chemicals sector as BASF pursues Evonik in a deal that would combine two major German groups. Evonik has rejected the initial approach as too low, even as the proposed premium raises fresh questions for management, shareholders and labour representatives.

Highlights

  • BASF made an initial €22.15 per share offer for Evonik, valuing it at €10.3bn equity and €14.2bn enterprise value, which Evonik rejected as too low.
  • Evonik shares traded at €19.29 on Monday after the bid was made public, while BASF shares fell 3.6 percent as investors demanded clarification on the deal's outlook.
  • RAG-Stiftung’s position, labour concerns over potential job cuts, and integration risks are key hurdles for the proposed merger targeting €74bn combined revenues.

Bid terms and takeover hurdles

As first reported by the Financial Times, BASF recently offered about €22.15 a share for Evonik in an initial proposal, valuing the target’s equity at €10.3bn and implying an enterprise value of roughly €14.2bn, according to Bloomberg data. People familiar with the matter said Evonik considered the offer too low to justify formal negotiations or to allow BASF to conduct due diligence.

The proposed price represents a premium of nearly 29 per cent to Evonik’s share price last Monday, before takeover speculation became public. Evonik said last week that it had received a nonbinding approach but that no talks are currently taking place, while BASF said it had held exploratory discussions with both Evonik and its largest shareholder, RAG-Stiftung, and that the course and outcome remain open.

BASF said in a statement on Monday that an acquisition of Evonik would strengthen and complement its core businesses and that it would remain disciplined in its approach. The group also said any synergies can be validated only with Evonik’s engagement.

Shareholder, labour and industry implications

The size of the premium is likely to increase pressure on Evonik’s management and on RAG-Stiftung, which owns 44 per cent of the company, to explain their reluctance to engage. Evonik shares were trading at €19.29 on Monday afternoon, while BASF investors are also likely to seek clarification after the company’s shares fell 3.6 per cent on Friday when the approach became public.

A combination would be a significant step by BASF chief executive Markus Kamieth to consolidate Europe’s fragmented chemicals industry and build greater scale against Chinese competitors including Sinopec and U.S. rivals such as Dow. At the same time, any merger could trigger job cuts and asset sales to address overlaps, forcing shareholders, executives and politicians to weigh the benefits of creating a Germany-based group with combined revenues of €74bn against the risks and costs of integration.

RAG-Stiftung’s stance is central to any possible deal. The foundation, created in 2007 to manage the phaseout of Germany’s hard coal mining industry, has a board of trustees that includes North Rhine-Westphalia premier Hendrik Wüst, German finance minister Lars Klingbeil and economy minister Katherina Reiche.

Labour concerns are already emerging. Michael Vassiliadis, head of the IGBCE chemicals and energy union and a member of RAG’s board of trustees as well as BASF’s supervisory board, has recused himself from decisions on the potential takeover, according to people familiar with the matter, but warned on Monday that simply creating a larger company would not automatically benefit workers or production sites. He called for commitments on investment and on the future of German and European operations.

The approach comes as both companies are already restructuring around core activities. BASF is selling peripheral assets and cutting costs and jobs, while Evonik is reducing headcount, closing plants and selling non-core assets, against a backdrop of high energy costs, weaker demand, global overcapacity and rising overseas competition in Germany’s chemicals industry.

Thyssenkrupp Steel Europe’s turnaround plan outlined a push to at least triple core profit over the medium term, with management targeting adjusted EBITDA of at least €1.2bn versus about €400m expected this fiscal year. Our earlier coverage highlighted that the goal relies on capacity reductions, job cuts and continued trade protections against low-priced Asian steel imports. The case illustrated how major European industrial players are leaning on restructuring and external protections to defend margins in a challenging market.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.